Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
A2614 Bortezomib (PS-341)54 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A4393 Paclitaxel (Taxol)28 CitationTarget: Microtubules/TubulinsSummary: microtubule depolymerization inhibitor -
A3966 Doxorubicin37 CitationSummary: DNA topoisomerase II inhibitor -
A8487 Nocodazole8 CitationTarget: Microtubules/TubulinsSummary: microtubule polymerization inhibitor -
A2571 Pepstatin A9 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor -
A2585 MG-132129 CitationTarget: ProteasomeSummary: proteasome inhibitor -
A8883 SAR40533 CitationSummary: Selective ATP-competitive inhibitor of Vps34 -
A8627 Bafilomycin A132 CitationSummary: V-ATPases inhibitor -
A2583 Lactacystin (Synthetic)1 CitationTarget: ProteasomeSummary: Proteasome inhibitor -
A2606 Epoxomicin35 CitationSummary: proteasome inhibitor

